Clinical Decision Demo · PeptidePilot

Contraindication
Screening Tool

Enter a patient profile, select target peptides, and get a risk assessment with triggered contraindication rules and current FDA regulatory status.

This screening logic updates automatically when the FDA reclassifies a substance — last updated May 2026. Current 503A status reflects the substance status board on the FDA Peptide Compounding Tracker.
Demo mode — Fill in the patient profile and select peptides below, then click Run Screening. All contraindication logic runs locally in your browser. No patient data is transmitted.
1
Patient Profile
2
Current Medications

Quick picks

3
Select Peptides to Screen

Select one or more — FDA 503A status shown

Screening Results

Risk assessment based on entered profile

⬡

Complete patient profile, add medications, select peptides, then click Run Screening.

PeptidePilot is compliance infrastructure, not legal advice. FDA regulatory categories reflect Section 503A/503B compounding status as of May 2026. Clinic operators retain independent regulatory counsel for their specific obligations.